FINWIRES · TerminalLIVE
FINWIRES

生産者物価指数とレッドブックの発表を控え、火曜日の早朝、米ドルは下落した。

-- 火曜日の早朝、米ドルは主要貿易相手国通貨に対して下落した。これは、午前8時30分(東部時間)に発表される3月の生産者物価指数と、午前8時55分(東部時間)に発表されるレッドブック週間既存店売上高の発表を控えてのことである。 シカゴ連銀のオースタン・グールズビー総裁は午前9時45分と午前0時10分に講演を行う予定で、その後、マイケル・バー連邦準備銀行理事が午後0時45分、リッチモンド連銀のトム・バーキン総裁とボストン連銀のスーザン・コリンズ総裁が午後1時にそれぞれ講演を行う予定だ。 火曜日の早い時間帯には、全米独立企業連盟(NFIB)が、原油価格の高騰を受けて3月の企業景況感は引き続き低下したと発表した。 火曜日の為替レートの動向を簡単にまとめると以下の通り。 ユーロ/米ドルは、月曜日の米国市場終値の1.1761から1.1800に上昇し、月曜日の午前同時刻の1.1699から上昇した。火曜日のユーロ圏経済指標発表予定はありませんが、欧州中央銀行(ECB)政策委員会のフィリップ・レーン委員が午前10時(東部時間)と午前11時30分(東部時間)に講演を行い、続いて午後5時(東部時間)にクリスティーヌ・ラガルドECB総裁が講演を行う予定です。次回のECB会合は4月30日に予定されています。 英ポンド/米ドルは、月曜日の米国市場終値1.3506から1.3569に上昇し、月曜日の午前同時刻には1.3440でした。火曜日の英国経済指標発表予定はありませんが、イングランド銀行(BOE)のアンドリュー・ベイリー総裁が午後12時(東部時間)に講演を行い、続いて午後4時10分(東部時間)にサラ・ブリーデン政策委員会委員が講演を行う予定です。イングランド銀行の次回会合は4月30日に予定されています。 米ドル/円は、月曜日の米国市場終値159.3791円から158.7698円に下落し、月曜午前の同時刻には159.6980円でした。昨夜発表されたデータによると、日本の2月の鉱工業生産は減少しました。日本銀行の次回会合は4月27~28日に予定されています。 米ドル/カナダドルは、月曜日の米国市場終値1.3788円から1.3751円に下落し、月曜午前の同時刻には1.3836円でした。火曜日のカナダの経済指標発表予定はありません。カナダ銀行の次回会合は4月29日に予定されています。

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB